Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease

NCT01710462 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Change of company's strategy

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Pantoprazole + Domperidone
DRUG: Pantozol®

Sponsor

Eurofarma Laboratorios S.A.